Skip to main content
Clinical Trials/NCT02433548
NCT02433548
Completed
Phase 4

Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture

Centre Hospitalier Universitaire Vaudois1 site in 1 country30 target enrollmentOctober 2014

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Femoral Neck Fracture
Sponsor
Centre Hospitalier Universitaire Vaudois
Enrollment
30
Locations
1
Primary Endpoint
Pain scores at rest
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Femoral neck fracture is very common in the elderly and can produce severe to moderate pain. As this pathology is not life-threatening, waiting time in the emergency department may be prolonged due to the high number of unforeseen cases with patients remaining in pain.

Fascia iliaca block consists of injecting local anaesthetics below the fascia iliaca, resulting in the anaesthesia of the femoral, the lateral cutaneous and the obturator nerves, with effective analgesia.

Detailed Description

The objective of this trial is to compare the fascia iliaca block with a sham injection on patients arriving in the emergency department with a femoral neck fracture. The fascia iliaca block will be performed with an anatomical landmark technique and a volume of 30 mLs of bupivacaine 0.5% with epinephrine 5 mcg/mL will be injected.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
August 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Albrecht

PD Dr Eric Albrecht, MD, MER, DESA, Program Director, Regional Anaesthesia

Centre Hospitalier Universitaire Vaudois

Eligibility Criteria

Inclusion Criteria

  • patients with femoral neck fracture in the emergency department

Exclusion Criteria

  • presence of demencia
  • body weight less than 40kg
  • presence of a cancer or patients receiving chemotherapy
  • allergy to local anaesthetics

Outcomes

Primary Outcomes

Pain scores at rest

Time Frame: 45 minutes after the injection

Secondary Outcomes

  • Pain scores at rest(60 min, 4h, 8h, 12h, 24h after the injection)
  • Pain scores on movement(60 min, 4h, 8h, 12h, 24h after the injection)
  • Length of stay(up to 3 weeks)
  • Morphine consumption(60 min, 4h, 8h, 12h, 24h after the injection)

Study Sites (1)

Loading locations...

Similar Trials